State of Ohio Board of Pharmacy Extends Deadline for Office-Based Opioid Treatment Providers to Obtain Terminal Distributor License - The National Law Review
Ohio extends the deadline for Office-Based Opioid Treatment Providers to obtain a Terminal Distributor License.
Aforeworn detected this change in the Pharmacy & Controlled Substances space on August 21, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. Office-Based Opioid Treatment Providers in Ohio. should confirm how it applies to their specific situation before acting. There is a time constraint attached: New deadline not specified; check with the Ohio Board of Pharmacy for updates.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
The deadline for obtaining a Terminal Distributor License has been extended.
Who it affects
Office-Based Opioid Treatment Providers in Ohio.
What you must do
Providers must now ensure they obtain the Terminal Distributor License by the new deadline.
Deadline
New deadline not specified; check with the Ohio Board of Pharmacy for updates.
Never miss a change like this again
Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmacy & Controlled Substances
- Schedules of Controlled Substances: Temporary Placement of 5,6-Dichloro Brorphine, 5,6-Dichloro Desmethylchlorphine, N-Propionitrile Chlorphine, and Spirochlorphine in Schedule I of the Controlled Substances Act
- International Drug Scheduling; Single Convention on Narcotic Drugs; Convention on Psychotropic Substances; Clobromazolam (Phenazolam); Cychlorphine (N-Propionitrile Chlorphine); Desalkylgidazepam (Bromonordiazepam); Ethylbromazolam; Etomethazene (5-Methyl Etodesnitazene); Spirochlorphine (R6980); Etomidate; Medetomidine; Request for Comments
- PA HB 2749: An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for drug overdose medication.
- Schedules of Controlled Substances: Placement of Cipepofol in Schedule IV
- Catina Allen, N.P.; Decision and Order